Breast Cancer

Urbana, Ill. – A new study by Cancer Center at Illinois Education Program Leader, Zeynep Madak-Erdogan and her team, have found a new mechanism of endocrine resistance in breast cancers metastasized to the liver.

A graduate student in the School of Molecular & Cellular Biology competed in the Illinois Graduate College's Research Live! Showcase at the Krannert Center for Performing Arts.

The University of Illinois Urbana-Champaign recently hosted the 4th Big Ten Academic Alliance Lipid meeting, bringing together dozens of scientists from across the country to share their expertise on how lipids impact metabolic diseases.

For decades, Professor Benita S. Katzenellenbogen has focused on understanding breast cancer and women’s health, collaborating with scientists on campus and around the world to develop better treatments and reduce morbidities from the disease. Her research has provided the framework for the...

A new approach to treating breast cancer kills 95-100% of cancer cells in mouse models of human estrogen-receptor-positive breast cancers and their metastases in bone, brain, liver and lungs. The newly developed drug, called ErSO, quickly shrinks even large tumors to undetectable levels.

Nine interdisciplinary projects designed by University of Illinois Urbana-Champaign faculty, including several from the School of Molecular & Cellular Biology, were selected for the Cancer Center at Illinois (CCIL) annual seed grant awards.

Scientists working to understand the cellular processes linking high cholesterol to breast cancer recurrence and metastasis report that a byproduct of cholesterol metabolism causes some cells to send out cancer-promoting signals to other cells. These signals are packaged in membrane-bound...

Dr. Nelson’s lab focuses on determining how different hormones and metabolite factors impact breast and ovarian cancer progression.

Erik Nelson, professor of molecular and integrative physiology, has won a $4.5 million Era of Hope Scholar Award from the United States Department of Defense Breast Cancer Research Program.This prestigious award supports individuals early in their careers who have demonstrated significant potential...

University of Illinois researchers are leading the science behind a new global licensing agreement between the pharmaceutics company Bayer AG and the cancer drug development company Systems Oncology for a new breast cancer drug called ERSO.